Content provided in partnership with

Family Health Acquires Pharmalink

BT Catalyst, Sept, 1999

Family Health International of Research Triangle Park has acquired PharmaLink, a new CRO that specializes in Internet management of clinical trials conducted at multiple study sites.

PharmaLink was acquired using profits from FHI's work for private industry.

Financial details of the acquisition, which was completed in June, were not released.

Established in 1998, Durham-based PhamaLink was one of the first companies to offer Web-based clinical trials to pharmaceutical and biotechnology companies, said Stephen D. Corman, who was PharmaLink's chief executive and previously was executive vice president and chief financial officer of Burroughs Wellcome Co. "Combining our specialized services with FHI's proven record for managing large-scale clinical trials on a global basis is an ideal match of complementary talents, creating a vigorous, full-service contract research organization," he said.

Most Popular Articles in Technology: An overview of continuous data protection; Why all those current ratings?; Many countries now have a mobile penetration rate above 100%, report says; The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...; MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...; More »

PharmaLink retains its name as a separate company under the FHI Group. Corman continues to serve as a member of PharmaLink's board of directors and as a consultant. Dr. Albert J. Siemens, Family Health's chief executive officer, also serves as PharmaLink's president and chief executive officer. R. Peyton Woodson III, of Raleigh-based Woodson Associates, is chairman of PharmaLink's board of directors.

FHI's contract clinical research focuses primarily on women's health and infectious diseases.

The company has more than 400 employees worldwide and has conducted clinical studies in more than 50 countries.

During the past 28 years, FHI and its affiliates have conducted hundreds of studies throughout the world, at times involving thousands of human volunteers at many study centers. These trials have resulted in the registration and introduction of medical devices and pharmaceuticals in the United States, Asia, Latin America, Africa and Europe. Many of FHI's current studies focus on reproductive-tract infections, HIV/AIDS and women's health.

Technology Industry

Family Health Acquires Pharmalink

BT Catalyst, Sept, 1999

Find Research Guides for:

Find Featured Titles for: Sports

Most Popular Articles in Technology

Most Popular Publications in Technology